Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading on Nasdaq under the ticker FLAC, was a blank-check company sponsored by Frazier Life Sciences and focused on the life sciences and biopharmaceutical sector. The SPAC completed its initial public offering in 2020, targeting acquisition opportunities within healthcare and drug development. On December 2, 2022, the company filed a Form 15-12G with the SEC under accession number 0001193125-22-297570, formally terminating its registration under the Securities Exchange Act — a step that typically marks the conclusion of a SPAC's registered life following a completed combination or a wind-down. FLAC is now deregistered. Sign up on SpacDesk for full sponsor histories, filing timelines, and status data across the SPAC universe.